D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 86 Citations 27,503 178 World Ranking 1899 National Ranking 1069

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Amino acid

Graham Carpenter mainly focuses on Cell biology, Epidermal growth factor, Biochemistry, Receptor and Tyrosine kinase. The various areas that Graham Carpenter examines in his Cell biology study include ROR1, Transmembrane protein and Mechanism of action. His Epidermal growth factor research incorporates themes from Cell surface receptor, Endocrinology and In vitro.

His research investigates the connection between Receptor and topics such as Cell that intersect with problems in Intracellular. Graham Carpenter has researched Tyrosine kinase in several fields, including Molecular biology, Receptor tyrosine kinase, Phosphorylation and Platelet-derived growth factor receptor. His biological study spans a wide range of topics, including Tyrosine and Phospholipase C.

His most cited work include:

  • Epidermal growth factor. (2023 citations)
  • Receptors for epidermal growth factor and other polypeptide mitogens. (1145 citations)
  • 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. (1120 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Cell biology, Epidermal growth factor, Biochemistry, Molecular biology and Receptor. His study in Receptor tyrosine kinase, Phosphorylation, Growth factor receptor, Signal transduction and Growth factor receptor inhibitor are all subfields of Cell biology. His studies deal with areas such as Protein tyrosine phosphatase, Tyrosine kinase, Proto-oncogene tyrosine-protein kinase Src and ROR1, Platelet-derived growth factor receptor as well as Receptor tyrosine kinase.

Graham Carpenter focuses mostly in the field of Epidermal growth factor, narrowing it down to matters related to Endocrinology and, in some cases, Cell culture. Graham Carpenter combines subjects such as Cell, Glycosylation and Cell growth with his study of Receptor. His study in Phospholipase C is interdisciplinary in nature, drawing from both Phospholipase and Second messenger system.

He most often published in these fields:

  • Cell biology (53.51%)
  • Epidermal growth factor (49.73%)
  • Biochemistry (36.76%)

What were the highlights of his more recent work (between 2000-2020)?

  • Cell biology (53.51%)
  • Receptor tyrosine kinase (22.70%)
  • Molecular biology (28.11%)

In recent papers he was focusing on the following fields of study:

Graham Carpenter spends much of his time researching Cell biology, Receptor tyrosine kinase, Molecular biology, ErbB and Biochemistry. His Cell biology research includes themes of Receptor and Epidermal growth factor. As a part of the same scientific study, he usually deals with the Epidermal growth factor, concentrating on Growth factor and frequently concerns with Phospholipase C activation.

His Receptor tyrosine kinase research integrates issues from Cell, Tyrosine kinase, Proto-oncogene tyrosine-protein kinase Src and ROR1, Platelet-derived growth factor receptor. Graham Carpenter has included themes like Ionomycin, Mitogen-activated protein kinase kinase and Kinase activity in his Molecular biology study. Graham Carpenter interconnects Regulation of gene expression, Kinase, Ectodomain and Neuregulin in the investigation of issues within ErbB.

Between 2000 and 2020, his most popular works were:

  • γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase (781 citations)
  • HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors. (355 citations)
  • ErbB receptors: new insights on mechanisms and biology (284 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Epidermal growth factor.

G Carpenter;S Cohen.
Journal of Biological Chemistry (1972)

3346 Citations

125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.

Graham Carpenter;Stanley Cohen.
Journal of Cell Biology (1976)

1816 Citations

Receptors for epidermal growth factor and other polypeptide mitogens.

Graham Carpenter.
Annual Review of Biochemistry (1987)

1815 Citations

γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase

Chang-Yuan Ni;M. Paul Murphy;Todd E. Golde;Graham Carpenter.
Science (2001)

1000 Citations

Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation.

S Nishibe;MI Wahl;SM Hernandez-Sotomayor;NK Tonks.
Science (1990)

827 Citations

Human epidermal growth factor: isolation and chemical and biological properties

Stanley Cohen;Graham Carpenter.
Proceedings of the National Academy of Sciences of the United States of America (1975)

638 Citations

Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts.

G Carpenter;K J Lembach;M M Morrison;S Cohen.
Journal of Biological Chemistry (1975)

578 Citations

Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro.

Graham Carpenter;Lloyd King;Stanley Cohen.
Nature (1978)

565 Citations

Human epidermal growth factor and the proliferation of human fibroblasts.

Graham Carpenter;Stanley Cohen.
Journal of Cellular Physiology (1976)

547 Citations

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.

Shizhen Emily Wang;Archana Narasanna;Marianela Perez-Torres;Bin Xiang.
Cancer Cell (2006)

533 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Graham Carpenter

Yosef Yarden

Yosef Yarden

Weizmann Institute of Science

Publications: 96

Joseph Schlessinger

Joseph Schlessinger

Yale University

Publications: 70

Klaus Elenius

Klaus Elenius

University of Turku

Publications: 60

Axel Ullrich

Axel Ullrich

Max Planck Institute of Biochemistry

Publications: 55

Pier Paolo Di Fiore

Pier Paolo Di Fiore

University of Milan

Publications: 47

Pann-Ghill Suh

Pann-Ghill Suh

Korea Brain Research Institute

Publications: 46

Mien Chie Hung

Mien Chie Hung

China Medical University

Publications: 46

Carl-Henrik Heldin

Carl-Henrik Heldin

Uppsala University

Publications: 46

Renato Baserga

Renato Baserga

Thomas Jefferson University

Publications: 41

Alan Wells

Alan Wells

University of Pittsburgh

Publications: 40

Alexander Sorkin

Alexander Sorkin

University of Pittsburgh

Publications: 39

Douglas A. Lauffenburger

Douglas A. Lauffenburger

MIT

Publications: 37

Bengt Westermark

Bengt Westermark

Uppsala University

Publications: 36

Sung Ho Ryu

Sung Ho Ryu

Pohang University of Science and Technology

Publications: 35

Antony W. Burgess

Antony W. Burgess

Walter and Eliza Hall Institute of Medical Research

Publications: 34

Morley D. Hollenberg

Morley D. Hollenberg

University of Calgary

Publications: 34

Trending Scientists

Chun-Cheng Lin

Chun-Cheng Lin

National Tsing Hua University

Geoffrey R. Spedding

Geoffrey R. Spedding

University of Southern California

Jun Yu

Jun Yu

Chinese University of Hong Kong

Weihua Zhang

Weihua Zhang

Imperial College London

Patrick Sorgeloos

Patrick Sorgeloos

Ghent University

Iain M. Hagan

Iain M. Hagan

University of Manchester

Enrique Rodriguez-Boulan

Enrique Rodriguez-Boulan

Cornell University

W. Gibson Wood

W. Gibson Wood

University of Minnesota

F. L. Scarf

F. L. Scarf

Northrop Grumman (United States)

David R. Curtis

David R. Curtis

Australian National University

Alain Townsend

Alain Townsend

University of Oxford

Mariana J. Kaplan

Mariana J. Kaplan

National Institutes of Health

John C. Turner

John C. Turner

Australian National University

Tim Dalgleish

Tim Dalgleish

University of Cambridge

Dominique S. Michaud

Dominique S. Michaud

Tufts University

Mark E. Schaffer

Mark E. Schaffer

Heriot-Watt University

Something went wrong. Please try again later.